PMID- 24939858 OWN - NLM STAT- MEDLINE DCOM- 20150330 LR - 20211021 IS - 1873-7064 (Electronic) IS - 0028-3908 (Print) IS - 0028-3908 (Linking) VI - 85 DP - 2014 Oct TI - Locomotor conditioning by amphetamine requires cyclin-dependent kinase 5 signaling in the nucleus accumbens. PG - 243-52 LID - S0028-3908(14)00200-7 [pii] LID - 10.1016/j.neuropharm.2014.05.033 [doi] AB - Intermittent systemic exposure to psychostimulants leads to several forms of long-lasting behavioral plasticity including nonassociative sensitization and associative conditioning. In the nucleus accumbens (NAcc), the protein serine/threonine kinase cyclin-dependent kinase 5 (Cdk5) and its phosphorylation target, the guanine-nucleotide exchange factor kalirin-7 (Kal7), may contribute to the neuroadaptations underlying the formation of conditioned associations. Pharmacological inhibition of Cdk5 in the NAcc prevents the increases in dendritic spine density normally observed in this site following repeated cocaine. Mice lacking the Kal7 gene display similar effects. As increases in spine density may relate to the formation of associative memories and both Cdk5 and Kal7 regulate the generation of spines following repeated drug exposure, we hypothesized that either inhibiting Cdk5 or preventing its phosphorylation of Kal7 in the NAcc may prevent the induction of drug conditioning. In the present experiments, blockade in rats of NAcc Cdk5 activity with roscovitine (40 nmol/0.5 mul/side) prior to each of 4 injections of amphetamine (1.5 mg/kg; i.p.) prevented the accrual of contextual locomotor conditioning but spared the induction of locomotor sensitization as revealed on tests conducted one week later. Similarly, transient viral expression in the NAcc exclusively during amphetamine exposure of a threonine-alanine mutant form of Kal7 [mKal7(T1590A)] that is not phosphorylated by Cdk5 also prevented the accrual of contextual conditioning and spared the induction of sensitization. These results indicate that signaling via Cdk5 and Kal7 in the NAcc is necessary for the formation of context-drug associations, potentially through the modulation of dendritic spine dynamics in this site. CI - Copyright (c) 2014 Elsevier Ltd. All rights reserved. FAU - Singer, Bryan F AU - Singer BF AD - Committee on Neurobiology, The University of Chicago, Chicago, IL, USA. FAU - Neugebauer, Nichole M AU - Neugebauer NM AD - Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, IL, USA. FAU - Forneris, Justin AU - Forneris J AD - Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, IL, USA. FAU - Rodvelt, Kelli R AU - Rodvelt KR AD - Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, IL, USA. FAU - Li, Dongdong AU - Li D AD - Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, IL, USA. FAU - Bubula, Nancy AU - Bubula N AD - Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, IL, USA. FAU - Vezina, Paul AU - Vezina P AD - Committee on Neurobiology, The University of Chicago, Chicago, IL, USA; Department of Psychiatry and Behavioral Neuroscience, The University of Chicago, Chicago, IL, USA. Electronic address: pvezina@yoda.bsd.uchicago.edu. LA - eng GR - UL1 TR000430/TR/NCATS NIH HHS/United States GR - F31 DA030021/DA/NIDA NIH HHS/United States GR - T32 DA07255/DA/NIDA NIH HHS/United States GR - T32 DA007255/DA/NIDA NIH HHS/United States GR - R01 DA09397/DA/NIDA NIH HHS/United States GR - R01 DA009397/DA/NIDA NIH HHS/United States GR - F31 DA030021-01A1/DA/NIDA NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20140602 PL - England TA - Neuropharmacology JT - Neuropharmacology JID - 0236217 RN - 0 (Central Nervous System Stimulants) RN - 0 (Guanine Nucleotide Exchange Factors) RN - 0 (Kalrn protein, rat) RN - 0 (Protein Kinase Inhibitors) RN - 0 (Purines) RN - 0ES1C2KQ94 (Roscovitine) RN - CK833KGX7E (Amphetamine) RN - EC 2.7.11.1 (Cyclin-Dependent Kinase 5) RN - EC 2.7.11.22 (Cdk5 protein, rat) SB - IM MH - Amphetamine/*pharmacology MH - Animals MH - Central Nervous System Stimulants/*pharmacology MH - Conditioning, Psychological/*drug effects/physiology MH - Cyclin-Dependent Kinase 5/antagonists & inhibitors/*metabolism MH - Guanine Nucleotide Exchange Factors/genetics/metabolism MH - Male MH - Motor Activity/*drug effects/physiology MH - Mutation MH - Nucleus Accumbens/*drug effects/physiology MH - Phosphorylation/drug effects MH - Protein Kinase Inhibitors/pharmacology MH - Purines/pharmacology MH - Rats, Sprague-Dawley MH - Roscovitine MH - Signal Transduction/drug effects PMC - PMC4107072 MID - NIHMS602425 OTO - NOTNLM OT - Conditioning OT - Dendritic spines OT - Learning OT - Memory OT - Psychostimulants OT - Roscovitine OT - Sensitization EDAT- 2014/06/19 06:00 MHDA- 2015/03/31 06:00 PMCR- 2015/10/01 CRDT- 2014/06/19 06:00 PHST- 2014/03/01 00:00 [received] PHST- 2014/05/16 00:00 [revised] PHST- 2014/05/18 00:00 [accepted] PHST- 2014/06/19 06:00 [entrez] PHST- 2014/06/19 06:00 [pubmed] PHST- 2015/03/31 06:00 [medline] PHST- 2015/10/01 00:00 [pmc-release] AID - S0028-3908(14)00200-7 [pii] AID - 10.1016/j.neuropharm.2014.05.033 [doi] PST - ppublish SO - Neuropharmacology. 2014 Oct;85:243-52. doi: 10.1016/j.neuropharm.2014.05.033. Epub 2014 Jun 2.